55 related articles for article (PubMed ID: 23228931)
1. Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice?
Hemmeryckx B; Hoylaerts MF; Gallacher DJ; Rong Lu H; Himmelreich U; D'hooge J; Swinnen M; Lijnen HR
Eur J Pharmacol; 2013 Jan; 700(1-3):23-31. PubMed ID: 23228931
[TBL] [Abstract][Full Text] [Related]
2. Effect of rosiglitazone on liver structure and function in genetically diabetic Akita mice.
Hemmeryckx B; Gaekens M; Gallacher DJ; Lu HR; Lijnen HR
Basic Clin Pharmacol Toxicol; 2013 Nov; 113(5):353-60. PubMed ID: 23789962
[TBL] [Abstract][Full Text] [Related]
3. Effect of sitagliptin treatment on metabolism and cardiac function in genetic diabetic mice.
Hemmeryckx B; Swinnen M; Gallacher DJ; Rong Lu H; Roger Lijnen H
Eur J Pharmacol; 2014 Jan; 723():175-80. PubMed ID: 24406339
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
5. Prolonged decrease of adipocyte size after rosiglitazone treatment in high- and low-fat-fed rats.
Johnson JA; Trasino SE; Ferrante AW; Vasselli JR
Obesity (Silver Spring); 2007 Nov; 15(11):2653-63. PubMed ID: 18070756
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model.
Luconi M; Mangoni M; Gelmini S; Poli G; Nesi G; Francalanci M; Pratesi N; Cantini G; Lombardi A; Pepi M; Ercolino T; Serio M; Orlando C; Mannelli M
Endocr Relat Cancer; 2010 Mar; 17(1):169-77. PubMed ID: 19955217
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone.
Larsen PJ; Lykkegaard K; Larsen LK; Fleckner J; Sauerberg P; Wassermann K; Wulff EM
Eur J Pharmacol; 2008 Oct; 596(1-3):173-9. PubMed ID: 18761337
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.
Fraulob JC; Souza-Mello V; Aguila MB; Mandarim-de-Lacerda CA
Clin Sci (Lond); 2012 Aug; 123(4):259-70. PubMed ID: 22420611
[TBL] [Abstract][Full Text] [Related]
9. Effect of rosiglitazone on the expression of cardiac adiponectin receptors and NADPH oxidase in type 2 diabetic rats.
Guo Z; Qin Z; Zhang R; Li J; Yin Y
Eur J Pharmacol; 2012 Jun; 685(1-3):116-25. PubMed ID: 22542658
[TBL] [Abstract][Full Text] [Related]
10. Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain.
Sotiropoulos KB; Clermont A; Yasuda Y; Rask-Madsen C; Mastumoto M; Takahashi J; Della Vecchia K; Kondo T; Aiello LP; King GL
FASEB J; 2006 Jun; 20(8):1203-5. PubMed ID: 16672634
[TBL] [Abstract][Full Text] [Related]
11. Effects of high-fat diet on plasma lipids, adiposity, and inflammatory markers in ovariectomized C57BL/6 mice.
Ludgero-Correia A; Aguila MB; Mandarim-de-Lacerda CA; Faria TS
Nutrition; 2012 Mar; 28(3):316-23. PubMed ID: 22079392
[TBL] [Abstract][Full Text] [Related]
12. The Ins2Akita mouse as a model of early retinal complications in diabetes.
Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic rosiglitazone treatment on renal handling of salt and water in rats with volume-overload congestive heart failure.
Goltsman I; Wang X; Lavallie ER; Diblasio-Smith EA; Ovcharenko E; Hoffman A; Abassi Z; Feuerstein GZ; Winaver J
Circ Heart Fail; 2011 May; 4(3):345-54. PubMed ID: 21398416
[TBL] [Abstract][Full Text] [Related]
14. Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat.
Davis J; Higginbotham A; O'Connor T; Moustaid-Moussa N; Tebbe A; Kim YC; Cho KW; Shay N; Adler S; Peterson R; Banz W
Ann Nutr Metab; 2007; 51(1):42-52. PubMed ID: 17356265
[TBL] [Abstract][Full Text] [Related]
15. Gene expression and adiposity are modified by soy protein in male Zucker diabetic fatty rats.
Banz WJ; Davis J; Peterson R; Iqbal MJ
Obes Res; 2004 Dec; 12(12):1907-13. PubMed ID: 15687389
[TBL] [Abstract][Full Text] [Related]
16. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha.
Bouter B; Geary N; Langhans W; Asarian L
Metabolism; 2010 Jul; 59(7):1065-73. PubMed ID: 20045154
[TBL] [Abstract][Full Text] [Related]
17. High-cholesterol diet augments endothelial dysfunction via elevated oxidative stress and reduced tetrahydrobiopterin in Ins2(Akita) mice, an autosomal dominant mutant type 1 diabetic model.
Yang XQ; Chen AF
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):764-9. PubMed ID: 19207718
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid/docosahexaenoic acid-supplemented diet in early life reduces body weight gain, plasma lipids, and adiposity in later life in ApoE*3Leiden mice.
Wielinga PY; Harthoorn LF; Verschuren L; Schoemaker MH; Jouni ZE; van Tol EA; Kleemann R; Kooistra T
Mol Nutr Food Res; 2012 Jul; 56(7):1081-9. PubMed ID: 22611002
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of adipose tissue redistribution with rosiglitazone treatment in various adipose depots.
Kang JG; Park CY; Ihm SH; Yoo HJ; Park H; Rhee EJ; Won JC; Lee WY; Oh KW; Park SW; Kim SW
Metabolism; 2010 Jan; 59(1):46-53. PubMed ID: 19716145
[TBL] [Abstract][Full Text] [Related]
20. Mango modulates body fat and plasma glucose and lipids in mice fed a high-fat diet.
Lucas EA; Li W; Peterson SK; Brown A; Kuvibidila S; Perkins-Veazie P; Clarke SL; Smith BJ
Br J Nutr; 2011 Nov; 106(10):1495-505. PubMed ID: 21733317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
